CIK 0001279704 · Non-accelerated filer<br>Smaller reporting company
Cellectar Biosciences, Inc.
Sign in to watch- Ticker
- CLRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043321804
- Phone
- (608) 441-8120
- Business address
- 100 CAMPUS DRIVE, FLORHAM PARK, NJ, 07932
- Former names
- NOVELOS THERAPEUTICS, INC., COMMON HORIZONS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 37 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-12 | NEIS JOHN Director | Sale | −198 | $3.70 | $732 | 10 |
| 2018-11-29 | HILL STEPHEN A Director | Sale | −939 | $2.21 | $2K | 53 |
| 2018-11-29 | HILL STEPHEN A Director | Sale | −53 | $2.21 | $117 | 0 |
| 2018-03-13 | Longcor Jarrod Chief Business Officer | Sale | −13,000 | $1.18 | $15K | 67,000 |
| 2018-03-12 | CARUSO JAMES V President and CEO | Sale | −34,000 | $1.20 | $41K | 213,548 |
| 2017-11-14 | NEIS JOHN Director | Sale | −5,214 | $1.49 | $8K | 626,103 |
| 2016-10-31 | Hertzberg Richard significant owner | Sale | −21,000 | $2.03 | $43K | 280,000 |
Page 1 of 1 · 7 trades